Literature DB >> 22734600

Influence of culture medium composition on relative mRNA abundances in domestic cat embryos.

R Hribal1, K Jewgenow, B C Braun, P Comizzoli.   

Abstract

Different culture conditions have been used to produce domestic cat embryos. As part of the in vitro procedures, the medium composition significantly affects the quality of the embryo development also. Quality assessments based on cleavage kinetics and blastomere symmetry are useful, but embryos also can differ in their relative gene expression patterns despite similar morphological characteristics. The aim of this study was to compare cat embryos produced with two different in vitro culture systems routinely used in two different laboratories [Smithsonian Conservation Biology Institute, Washington D.C., USA (SCBI) and Leibniz Institute for Zoo and Wildlife Research, Berlin, Germany (IZW)]. Specifically, relative mRNA expression patterns of critical genes for pre-implantation embryo development were assessed in both conditions. Embryos were produced in parallel in both culture systems by IVF using frozen-thawed ejaculated semen in the United States and fresh epididymal sperm in Germany. Success of embryo development in vitro was recorded as well as relative mRNA abundances [DNA methyltransferases 1 and 3A (DNMT1, DNMT3A), gap junction protein alpha 1 (GJA1), octamer-binding transcription factor 4 [OCT4], insulin-like growth factors 1 and 2 receptors (IGF1R, IGF2R), beta-actin (ACTB)] in pools of days 4-5 morulae by semi-quantitative RT-PCR assay. Percentages of cleaved embryos were similar (p > 0.05) between both culture systems, regardless of the location. OCT4 mRNA abundance was higher (p < 0.05) in embryos derived in the SCBI culture system compared with those from the IZW system when epididymal sperm was used for IVF. No clear correlation between the expression pattern and the culture system could be found for all other genes. It is suggested that OCT4 expression might be affected by the media composition in some conditions and can be the indicator of a better embryo quality.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734600     DOI: 10.1111/j.1439-0531.2012.02139.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  6 in total

1.  Meiotic maturation of oocytes recovered from the ovaries of Indian big cats at postmortem.

Authors:  Brahmasani Sambasiva Rao; Yelisetti Uma Mahesh; Komjeti Suman; Katari Venu Charan; Rhisita Nath; K Ramachander Rao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-15       Impact factor: 2.416

2.  The effect of vitrification and in vitro culture on the adenosine triphosphate content and mitochondrial distribution of mouse pre-implantation embryos.

Authors:  Mahboobeh Amoushahi; Mojdeh Salehnia; Saman HosseinKhani
Journal:  Iran Biomed J       Date:  2013

3.  Current State of In Vitro Embryo Production in African Lion (Panthera leo).

Authors:  Jennifer Zahmel; Kim Skalborg Simonsen; Julia Stagegaard; Sergio Eliseo Palma-Vera; Katarina Jewgenow
Journal:  Animals (Basel)       Date:  2022-05-31       Impact factor: 3.231

4.  Baicalin increases developmental competence of mouse embryos in vitro by inhibiting cellular apoptosis and modulating HSP70 and DNMT expression.

Authors:  Xiaonan Qi; Huatao Li; Xia Cong; Xin Wang; Zhongling Jiang; Rongfeng Cao; Wenru Tian
Journal:  J Reprod Dev       Date:  2016-07-29       Impact factor: 2.214

5.  IGF-I Medium Supplementation Improves Singly Cultured Cat Oocyte Maturation and Embryo Development In Vitro.

Authors:  Lorena Fernandez-Gonzalez; Valeria Kozhevnikova; Eugeny Brusentsev; Stefanie Jänsch; Sergei Amstislavsky; Katarina Jewgenow
Journal:  Animals (Basel)       Date:  2021-06-27       Impact factor: 2.752

Review 6.  Microarray analysis in pulmonary hypertension.

Authors:  Julia Hoffmann; Jochen Wilhelm; Andrea Olschewski; Grazyna Kwapiszewska
Journal:  Eur Respir J       Date:  2016-04-13       Impact factor: 16.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.